Results 201 to 210 of about 78,261 (320)
ABSTRACT Objectives The understanding of usefulness of immunoglobulin replacement therapy (IgRT) for hypogammaglobulinemia (HGG) in patients with hematologic malignancies (HM) has changed over time. This is mainly caused by the introduction of new treatment, such as B‐cell targeted agents.
Keichiro Mihara+5 more
wiley +1 more source
Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review. [PDF]
Lau BSR+6 more
europepmc +1 more source
Background: LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear.
Jiayan Wu+7 more
doaj
Should suspected early gallbladder cancer be treated laproscopically?
Steve T. Weiland+5 more
openalex +1 more source
Cardiac arrhythmias in cancer patients using the nationwide claim‐based database in Japan
The prevalence of cancer increased with time in view of cardio‐oncology or oncocardiology, which has organically developed as a new discipline. The data showed similar patterns of distribution in patients with both arrhythmias and ischemic heart diseases. Abstract Background Cardio‐oncology has recently developed as a new discipline.
Takashi Kobayashi, Kengo Kusano
wiley +1 more source
Establishment and validation of a novel prognostic nomogram for gallbladder cancer patients. [PDF]
Liu R+6 more
europepmc +1 more source
GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
Abstract Aims To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials. Materials and Methods A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks.
Giovanni Antonio Silverii+5 more
wiley +1 more source
Risk assessment of gallbladder cancer in patients with primary sclerosing cholangitis and gallbladder polyps: a systematic review. [PDF]
Grikyte I, Ignatavicius P.
europepmc +1 more source